Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Mar 15, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Neurocrine Biosciences Inc
|
0
|
$91.55 | -$2,263,589.20 |
—
| 29.51K |
Mar 13
|
Scheduled
| ||||||
Neurocrine Biosciences Inc
|
0
|
$91.40 | -$175,110.03 |
—
| 29.51K |
Mar 8 - Mar 11
|
Scheduled
| ||||||
Alkermes Plc.
|
0
|
—
|
—
|
—
|
0
| +1 |
Nov 17 - Feb 26
| ||||||
Neurocrine Biosciences Inc
|
0
|
$72.72 | -$1,792,347.00 |
—
| 29.51K |
Feb 20
|
Scheduled
| ||||||
Alkermes Plc.
| 126.79K |
$26.77 | -$2,456,334.89 | +12.04% | 1.18M | +1 |
Feb 8
| ||||||
Neurocrine Biosciences Inc
|
0
|
—
|
—
|
—
|
0
|
May 17
| |||||||
Alkermes Plc.
|
0
|
—
|
—
|
—
|
0
| +1 |
Feb 23
| ||||||
Alkermes Plc.
| 84.58K |
$28.01 | -$1,891,279.37 | +8.74% | 1.05M | +1 |
Feb 20 - Feb 21
| ||||||
Neurocrine Biosciences Inc
|
0
|
$65.96 | -$1,597,395.00 |
—
| 29.51K |
Jan 3
|
Scheduled
| ||||||
Neurocrine Biosciences Inc
|
0
|
—
|
—
|
—
|
0
|
May 18
| |||||||
Neurocrine Biosciences Inc
|
0
|
$41.48 | -$1,044,562.50 |
—
| 29.51K |
May 9
|
Scheduled
| ||||||
Alkermes Plc.
| 102.74K |
$22.27 | -$2,270,283.63 | +11.87% | 968.3K | +1 |
May 5 - May 6
| ||||||
Alkermes Plc.
| 18.01K |
$25.08 | -$360,800.88 | +2.13% | 865.56K | +1 |
Feb 18 - Feb 21
| ||||||
Alkermes Plc.
| 10.09K |
$26.79 | -$215,338.02 | +1.20% | 847.54K | +1 |
Feb 16
| ||||||
Alkermes Plc.
| 45.41K |
$30.60 | -$1,109,770.20 | +5.73% | 837.46K | +1 |
Sep 14
| ||||||
Neurocrine Biosciences Inc
|
0
|
—
|
—
|
—
|
0
|
May 19
| |||||||
Alkermes Plc.
|
0
|
$20.01 | -$569,655.00 |
—
| 792.04K | +1 |
May 18
|
Scheduled
| |||||
Alkermes Plc.
|
0
|
$20.10 | -$597,589.27 |
—
| 792.04K | +1 |
May 11
|
Scheduled
| |||||
Alkermes Plc.
|
0
|
$19.95 | -$368,910.00 |
—
| 792.04K | +1 |
May 6
|
Scheduled
| |||||
Alkermes Plc.
|
0
|
—
|
—
|
—
|
0
| +1 |
Feb 22
| ||||||
Alkermes Plc.
| 18.01K |
$19.58 | -$281,677.88 | +2.33% | 792.04K | +1 |
Feb 21
| ||||||
Alkermes Plc.
| 14.93K |
$19.85 | -$237,048.39 | +1.97% | 774.03K | +1 |
Feb 16 - Feb 17
| ||||||
Epizyme, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 29
| |||||||
Neurocrine Biosciences Inc
|
0
|
—
|
—
|
—
|
0
|
May 19
| |||||||
Alkermes Plc.
|
0
|
$13.37 | -$244,732.50 |
—
| 759.09K | +1 |
May 14
|
Scheduled
| |||||
Alkermes Plc.
|
0
|
$13.19 | -$144,265.00 |
—
| 759.09K | +1 |
May 7
|
Scheduled
| |||||
Alkermes Plc.
|
0
|
$12.77 | -$102,500.00 |
—
| 759.09K | +1 |
Apr 2
|
Scheduled
| |||||
Alkermes Plc.
|
0
|
$13.05 | -$196,725.00 |
—
| 759.09K | +1 |
Mar 26
|
Scheduled
| |||||
Alkermes Plc.
|
0
|
$13.11 | -$204,927.60 |
—
| 759.09K | +1 |
Mar 19
|
Scheduled
| |||||
Alkermes Plc.
| 9.73K |
$20.84 | -$161,926.80 | +1.30% | 759.09K | +1 |
Mar 1
| ||||||
Alkermes Plc.
| 18.01K |
$20.24 | -$291,172.64 | +2.46% | 749.36K | +1 |
Feb 20 - Feb 21
| ||||||
Alkermes Plc.
| 14.92K |
$17.77 | -$212,493.66 | +2.08% | 731.35K | +1 |
Feb 16 - Feb 17
| ||||||
Alkermes Plc.
|
0
|
$14.36 | -$1,029,000.00 |
—
| 716.43K | +1 |
Nov 14
|
Scheduled
| |||||
Alkermes Plc.
|
0
|
$14.50 | -$1,057,444.86 |
—
| 716.43K | +1 |
Nov 7 - Nov 8
|
Scheduled
| |||||
Alkermes Plc.
|
0
|
$15.38 | -$1,232,550.00 |
—
| 716.43K | +1 |
Sep 19
|
Scheduled
| |||||
Alkermes Plc.
|
0
|
$15.95 | -$1,347,220.00 |
—
| 716.43K | +1 |
Sep 12
|
Scheduled
| |||||
Alkermes Plc.
|
0
|
$14.70 | -$1,096,830.00 |
—
| 716.43K | +1 |
Sep 5
|
Scheduled
| |||||
Epizyme, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 31
| |||||||
Alkermes Plc.
|
0
|
$16.72 | -$1,795,928.00 |
—
| 716.43K | +1 |
May 16 - May 23
|
Scheduled
| |||||
Neurocrine Biosciences Inc
|
0
|
—
|
—
|
—
|
0
|
May 22
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.